微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 52.17% | 4.69% | 0.6% | 66/131 | 51.25% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 51.86% | 19.82% | 0.93% | 71/131 | 52.33% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 51.38% | 13.27% | 1.39% | 72/131 | 53.43% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 50.67% | 10.03% | 1.7% | 73/131 | 53.5% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 49.83% | -2.61% | 15.14% | 73/131 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 43.28% | 9.53% | -4.59% | 86/131 | 53.31% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 45.36% | 18.69% | -1.51% | 82/131 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 46.06% | 19.43% | -9.99% | 81/131 | 53.45% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 51.17% | 32.47% | 29.49% | 73/131 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 39.51% | -9.85% | 3.39% | 94/131 | 53.83% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 38.22% | -13.81% | -0.9% | 92/131 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 38.56% | -13.94% | -0.16% | 96/131 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 38.63% | 2% | -11.88% | 86/131 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 43.83% | 1.83% | -1.15% | 96/131 | 57.29% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 44.34% | 2% | -1.05% | 82/131 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 44.81% | -9.95% | 4.11% | 88/131 | 58.42% | 正海生物 | 90.78% | 行业排名> |
| 2020-12-31 | 43.04% | 12.26% | -13.51% | 101/131 | 59.59% | 正海生物 | 91.59% | 行业排名> |
| 2020-06-30 | 49.76% | 2% | 29.79% | 81/131 | 59.94% | 正海生物 | 92.23% | 行业排名> |
| 2019-12-31 | 38.34% | 4.11% | 4.11% | 92/131 | 56.37% | 正海生物 | 92.69% | 行业排名> |
| 2018-12-31 | 36.83% | 12.23% | 12.23% | 84/131 | 55.53% | 正海生物 | 92.61% | 行业排名> |
| 2017-12-31 | 32.81% | 2% | 2% | 85/131 | 55.34% | 正海生物 | 94.38% | 行业排名> |